Vnitr Lek 2018, 64(5):468-475 | DOI: 10.36290/vnl.2018.067

Differential diagnosis of anemia

Jan Válka*, Jaroslav Čermák
Ústav hematologie a krevní transfuze, Praha

Anemia, defined as hemoglobin level under lower normal limit, is a symptom of different pathologic conditions and the accurate differential diagnosis is necessary to determine the cause of anemia. The article uses the morphological classification of anemia to distinguish macrocytic, normocytic and microcytic types of anemias and divides anemias with increased amount of peripheral blood reticulocytes as a special group. It describes commonly known clinical units as iron deficiency anemia or anemia of chronic disease, as so as rare clinical units, which are always need to think about in a differential diagnosis of an anemic patient. There is an increasing incidence of rare blood disorders due to introduction of molecular genetics methods into diagnostics, prolonged overall survival of patients and increasing migration from areas with endemic occurrence of these diseases. Etiology, basic pathophysiological mechanisms, main clinical features together with important diagnostic examinations are described by each clinical unit. Due to the differential diagnostic focus of the article only basic knowledge about therapy is mentioned. The authors are members of the IHBT Center for Rare Disorders of Hematopoiesis, which is focused mainly on congenital and acquired disorders of red blood cell.

Keywords: anemia; differential diagnosis; enzymopathies; hemoglobinopathies; iron; macrocytosis; microcytosis; rare blood disorders; reticulocytosis

Received: December 18, 2017; Accepted: March 15, 2018; Published: May 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Válka J, Čermák J. Differential diagnosis of anemia. Vnitr Lek. 2018;64(5):468-475. doi: 10.36290/vnl.2018.067.
Download citation

References

  1. Buliková A. Anémie. In: Penka M, Buliková A et al. Neonkologická hematologie. 2. ed. Grada: Praha 2009: 39-95. ISBN 978-80-247-2299-3.
  2. Vydra J, Čermák J. Anémie. In: Vydra J, Cetkovský P (eds) et al. Hematologie v kostce. Mladá fronta: Praha 2015: 11-68. ISBN 978-80-204-3698-6.
  3. Camaschella C. Iron-deficiency anemia. N Engl J Med 2015; 372(19): 1832-1843. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1401038>. Go to original source... Go to PubMed...
  4. Nemeth E, Ganz T. Anemia of Inflammation. Hematol Oncol Clin N Am 2014; 28(4): 671-681, vi. Dostupné z DOI: <http://dx.doi.org/10.1016/j.hoc.2014.04.005>. Go to original source... Go to PubMed...
  5. Rund D, Rachmilewitz E. β thalassemia. N Engl J Med 2005; 353(11): 1135-1146. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra050436>. Go to original source... Go to PubMed...
  6. Divoka M, Partschova M, Kucerova J et al. Molecular characteristics of β-thalassemia in the Czech and Slovak populations: Mediterranean, Asian and unique mutations. Hemoglobin 2016; 40(3): 156-162. Dostupné z DOI: <http://dx.doi.org/10.3109/03630269.2016.1152581>. Go to original source... Go to PubMed...
  7. Harteveld CR, Higgs CR. α-thalassemia. Orphanet J Rare Dis 2010; 5: 13. Dostupné z DOI: <http://dx.doi.org/10.1186/1750-1172-5-13>. Go to original source... Go to PubMed...
  8. Čermák J. K diferenciální diagnostice a léčbě anémií. Remedia 2003; 13(4): 258-265.
  9. Bizzaro N, Antico A. Diagnosis and classification of pernicious anemia. Autoimmun Rev 2014; 13(4-5): 565-568. Dostupné z DOI: <http://dx.doi.org/10.1016/j.autrev.2014.01.042>. Go to original source... Go to PubMed...
  10. Papaemmanuil E, Gerstung M, Malcovati L et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 2013; 122(22): 3616-3627. Dostupné z DOI: <http://dx.doi.org/10.1182/blood-2013-08-518886>. Go to original source... Go to PubMed...
  11. Vlachos A, Ball S, Dahl N et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol 2008; 142(6): 859-876. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2141.2008.07269.x>. Go to original source... Go to PubMed...
  12. Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 2010; 24(3): 101-122. Dostupné z DOI: <http://dx.doi.org/10.1016/j.blre.2010.03.002>. Erratum in Blood Rev 2010; 24(4-5): 201. Go to original source... Go to PubMed...
  13. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med 1997; 336(19): 1365-1372. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJM199705083361906>. Go to original source... Go to PubMed...
  14. Čermák J. Myelodysplastický syndrom. In: Starý J, Mayer J (eds). Leukémie. Grada: Praha 2002: 221-234. ISBN 80-7169-991-8.
  15. D'Andrea AD, Grompe M. Molecular Biology of Fanconi Anemia: Implications for Diagnosis and Therapy. Blood 1997; 90(5): 1725-1736. Go to original source...
  16. Bolton-Maggs PHB, Langer JC, Iolascon A et al. Guidelines for the diagnosis and management of hereditary spherocytosis - 2011 update. Br J Haematol 2004; 156(1): 37-49. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2141.2011.08921.x>. Go to original source... Go to PubMed...
  17. Grace RF, Zanella A, Neufeld EJ et al. Erythrocyte pyruvate kinase deficiency: 2015 status report. Am J Hematol 2015; 90(9): 825-830. Dostupné z DOI: <http://dx.doi.org/10.1002/ajh.24088>. Go to original source... Go to PubMed...
  18. Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 2008; 111(1): 16-24. <http://dx.doi.org/10.1182/blood-2007-04-077412>. Go to original source... Go to PubMed...
  19. Stuart MJ, Nagel RL. Sickle cell disease. Lancet 2004; 364(9442): 1343-1360. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140-6736(04)17192-4>. Go to original source... Go to PubMed...
  20. Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica 2014; 99(10): 1547-1554. Dostupné z DOI: <http://dx.doi.org/10.3324/haematol.2014.114561>. Go to original source... Go to PubMed...
  21. Válka J. Paroxysmální noční hemoglobinurie pro praktické lékaře. XIV. kongres praktických lékařů v Praze - abstract. Med Praxi 2017; 14(Suppl E): 11.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.